Search results for: Market Access
Filter search results
Consolidation and Competition in the Pharmaceutical Industry
9 January 2001
…on the major changes in the innovation process over time, while Walton identifies the growth in both R&D and marketing costs relative to the growth in markets as a key…
OHE Annual Lecture Webinar 2020: How Should the World Pay for a COVID-19 Vaccine?
24 June 2020, 11:00pm
…large market risk for potential developers (would people want to buy it?) on top of substantial scientific risk (would the product work?). By the time a vaccine comes to market,…
Biosimilars and Data Exclusivity
8 June 2010
Data exclusivity is critical to ensuring that biosimilars achieve an appropriate balance between increasing market competition and encouraging innovation. The history of ‘traditional generics’ is a poor guide; biosimilars possess…
New Antimicrobial Drugs: EU Policy Options
4 October 2010
…development of new antibiotics requires understanding current disincentives. The authors identify four key sets of factors: (1) low returns in the market because of the availability of generics, the effects…
Biosimilar Competition: Lessons from Europe and Prospects for the US
2 December 2014
…how the US market may evolve. With respect to the European experience, the briefing looks at how the market for EMA-approved biosimilars in the area of erythropoietins (EPOs) and…
Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market
12 December 2017
This report explores the consequences of the exit of the United Kingdom (UK) from the European Union (EU) on public health in the UK and in the EU. A new…
How Should the World Pay for a COVID-19 Vaccine?
26 May 2020, 12:00am
…collaboration. Analysis will consider the work of Gavi and others to construct a global vaccine market that delivers for all citizens. Development and administration of a safe and effective vaccine,…
The Publicly Funded Vaccines Market in Australia
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in Australia. It includes observations as to whether and how the economic assessment process…
The Publicly Funded Vaccines Market in the UK
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in the UK. It includes observations as to whether and how the economic assessment…